China's Innovent raises $100 mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2015

Singapore: China biotech firm, Innovent Biologics, has raised $100 million in Series C financing led by Legend Capital, ...Read more

Network Verfication Challenge gains momentum

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2015

Singapore: Scientific consensus in the Network Verification Challenge, conducted in Spain from 15-18 June 2015, has exhi...Read more

Today scientists have poor frustration tolerance: Glivec discoverer

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 2 Comment | 25 Jun, 2013

Dr Alex Matter, CEO, Experimental Therapeutics Center, A*Star, Singapore, is among the pioneers of the world's first tar...Read more

Australia grants $7 mn to uplift cancer research

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 May, 2015

Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...Read more

Novogen progresses on drug for paediatric brain cancer

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2015

Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...Read more

WHO urges nations to act on hepatitis threat

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 26 Jul, 2013

Singapore: The World Health Organization (WHO) is urging governments to act against the five hepatitis viruses that can...Read more

Novogen develops drug to enhance chemotherapy effect

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2015

Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...Read more

Eloxatin shows +ve results in tumor inhibition

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

Singapore: Australia-based Starpharma Holdings has achieved improved tumor-inhibiting efficacy and reduced overall toxic...Read more

Oxycodone patch resumes clinical development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodo...Read more

Drug delivery: 11 technologies of the future

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

The drug delivery technology landscape is rapidly evolving with new classes of pharmaceuticals and biologics fuelling th...Read more

Starpharma appoints Robert Thomas as board member

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2013

Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...Read more

Australia supports budding medical researchers

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 May, 2015

Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...Read more

TGA approves chemotherapy-induced nausea and vomiting drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 May, 2015

Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...Read more

OTC drug may be key to multiple sclerosis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2015

Singapore: Two approved drugs, an antifungal and a steroid, may potentially take on new roles as treatments for multiple...Read more

Green tea for cancer drug delivery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Oct, 2014

Singapore: A group of researchers from Institute of Bioengineering and Nanotechnology (IBN) is using green tea ingredien...Read more

TauRx pumps $135mn to advance treatment for Alzheimer's disease

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2015

Singapore: Singapore and Scotland based TauRx Pharmaceuticals, a clinical-stage biopharmaceutical company developing a n...Read more

NIH: Gilead's sofosbuvir + ribavirin cures hepatitis C

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...Read more

Daiichi forms new firm to treat muscular dystrophy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2013

Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innov...Read more